Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2015

01-10-2015

Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results

Authors: Matthew P. Lungren, Thomas J. Ward, Manish N. Patel, John M. Racadio, Kamlesh Kukreja

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2015

Login to get access

Abstract

Nine patients (average age 8.3 years, range 20 days to 17 years; average weight 31 kg, range 2.7–79 kg) with catheter-associated UE-DVT underwent upper extremity venous thrombolysis with the goal of access salvage. Catheter directed therapy with alteplase (tPA), balloon angioplasty, and mechanical thrombectomy was used in all cases. The mean total dose of TPA was 15 mg (range 1–40 mg). Venous access was ultimately preserved in all patients. No stents or superior vena cava filters were used. There was one episode of symptomatic clinically suspected pulmonary embolism managed by systemic tPA and heparin without long term sequaele. Mean imaging and clinical follow-up was 351 ± 208 and 613 ± 498 days respectively. Endovenous thrombolysis for catheter-associated upper-extremity DVT in children may be safe and effective and could be considered particularly in patients in whom long-term venous access is needed.
Literature
1.
go back to reference Temple M, Williams S, John P et al (2005) Percutaneous treatment of pediatric thrombosis. Eur J Radiol 53:14–21CrossRefPubMed Temple M, Williams S, John P et al (2005) Percutaneous treatment of pediatric thrombosis. Eur J Radiol 53:14–21CrossRefPubMed
2.
go back to reference Tolbert J, Carpenter SL (2013) Common acquired causes of thrombosis in children. Curr Probl Pediatr Adolesc Health Care 43:169–177CrossRefPubMed Tolbert J, Carpenter SL (2013) Common acquired causes of thrombosis in children. Curr Probl Pediatr Adolesc Health Care 43:169–177CrossRefPubMed
3.
go back to reference Raffini L, Huang YS, Witmer C et al (2009) Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics 124:1001–1008CrossRefPubMed Raffini L, Huang YS, Witmer C et al (2009) Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics 124:1001–1008CrossRefPubMed
5.
go back to reference Massicotte MP, Dix D, Monagle P et al (1998) Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. J Pediatr 133:770–776CrossRefPubMed Massicotte MP, Dix D, Monagle P et al (1998) Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. J Pediatr 133:770–776CrossRefPubMed
6.
go back to reference Avila ML, Duan L, Cipolla A et al (2014) Postthrombotic syndrome following upper extremity deep vein thrombosis in children. Blood 124:1166–1173CrossRefPubMed Avila ML, Duan L, Cipolla A et al (2014) Postthrombotic syndrome following upper extremity deep vein thrombosis in children. Blood 124:1166–1173CrossRefPubMed
7.
go back to reference Kukreja KU, Lungren MP, Patel MN et al (2014) Endovascular venous thrombolysis in children younger than 24 months. J Vasc Interv Radiol 25:1158–1164CrossRefPubMed Kukreja KU, Lungren MP, Patel MN et al (2014) Endovascular venous thrombolysis in children younger than 24 months. J Vasc Interv Radiol 25:1158–1164CrossRefPubMed
8.
go back to reference NKF-DOQI clinical practice guidelines for vascular access (1997) National kidney foundation-dialysis outcomes quality initiative. Am J Kidney Dis 30:S150–191 NKF-DOQI clinical practice guidelines for vascular access (1997) National kidney foundation-dialysis outcomes quality initiative. Am J Kidney Dis 30:S150–191
9.
go back to reference Vo JN, Hoffer FA, Shaw DW (2010) Techniques in vascular and interventional radiology: pediatric central venous access. Tech Vasc Interv Radiol 13:250–257CrossRefPubMed Vo JN, Hoffer FA, Shaw DW (2010) Techniques in vascular and interventional radiology: pediatric central venous access. Tech Vasc Interv Radiol 13:250–257CrossRefPubMed
10.
go back to reference Shah PS, Shah VS (2008) Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev CD002772 Shah PS, Shah VS (2008) Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev CD002772
11.
go back to reference Pianta MJ, Thomson KR (2011) Catheter-directed thrombolysis of lower limb thrombosis. Cardiovasc Interv Radiol 34:25–36CrossRef Pianta MJ, Thomson KR (2011) Catheter-directed thrombolysis of lower limb thrombosis. Cardiovasc Interv Radiol 34:25–36CrossRef
12.
go back to reference Raffini L (2009) Thrombolysis for intravascular thrombosis in neonates and children. Curr Opin Pediatr 21:9–14CrossRefPubMed Raffini L (2009) Thrombolysis for intravascular thrombosis in neonates and children. Curr Opin Pediatr 21:9–14CrossRefPubMed
13.
go back to reference Laiho MK, Oinonen A, Sugano N et al (2004) Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. European J Vasc Endovasc Surg 28:391–396CrossRef Laiho MK, Oinonen A, Sugano N et al (2004) Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. European J Vasc Endovasc Surg 28:391–396CrossRef
15.
go back to reference Monagle P, Chan AK, Goldenberg NA et al (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e737S–801SPubMedCentralCrossRefPubMed Monagle P, Chan AK, Goldenberg NA et al (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e737S–801SPubMedCentralCrossRefPubMed
16.
go back to reference Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830CrossRefPubMed Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830CrossRefPubMed
17.
go back to reference Goldenberg NA, Donadini MP, Kahn SR et al (2010) Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 95:1952–1959PubMedCentralCrossRefPubMed Goldenberg NA, Donadini MP, Kahn SR et al (2010) Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 95:1952–1959PubMedCentralCrossRefPubMed
18.
go back to reference Goldenberg NA, Durham JD, Knapp-Clevenger R et al (2007) A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood 110:45–53PubMedCentralCrossRefPubMed Goldenberg NA, Durham JD, Knapp-Clevenger R et al (2007) A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood 110:45–53PubMedCentralCrossRefPubMed
19.
go back to reference Kukreja K GR, Chima R, Ristagno R, Racadio J (2013) Developing a pediatric endovascular thrombolysis program: a single-center experience. Pediatr Radiol 48(3):1024–1029CrossRef Kukreja K GR, Chima R, Ristagno R, Racadio J (2013) Developing a pediatric endovascular thrombolysis program: a single-center experience. Pediatr Radiol 48(3):1024–1029CrossRef
20.
go back to reference Vedantham S, Grassi CJ, Ferral H et al (2009) Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 20:S391–408CrossRefPubMed Vedantham S, Grassi CJ, Ferral H et al (2009) Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 20:S391–408CrossRefPubMed
21.
go back to reference Mitchell LG, Goldenberg NA, Male C et al (2011) Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost 9:1856–1858CrossRefPubMed Mitchell LG, Goldenberg NA, Male C et al (2011) Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost 9:1856–1858CrossRefPubMed
22.
23.
go back to reference Goldenberg NA, Bernard TJ (2010) Venous thromboembolism in children. Hematol Oncol Clin North Am 24:151–166CrossRefPubMed Goldenberg NA, Bernard TJ (2010) Venous thromboembolism in children. Hematol Oncol Clin North Am 24:151–166CrossRefPubMed
24.
go back to reference Vu LT, Nobuhara KK, Lee H et al (2008) Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg 43:1095–1099CrossRefPubMed Vu LT, Nobuhara KK, Lee H et al (2008) Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg 43:1095–1099CrossRefPubMed
25.
go back to reference Koury JP, Burke CT (2011) Endovascular management of acute upper extremity deep venous thrombosis and the use of superior vena cava filters. Semin Interv Radiol 28:3–9CrossRef Koury JP, Burke CT (2011) Endovascular management of acute upper extremity deep venous thrombosis and the use of superior vena cava filters. Semin Interv Radiol 28:3–9CrossRef
26.
go back to reference Maher KO, Clay MA, Kim D et al (2011) Utility of bedside angiography in the evaluation of vascular obstruction in the pediatric intensive care patient. Pediatr Crit Care Med 12:442–444CrossRefPubMed Maher KO, Clay MA, Kim D et al (2011) Utility of bedside angiography in the evaluation of vascular obstruction in the pediatric intensive care patient. Pediatr Crit Care Med 12:442–444CrossRefPubMed
27.
go back to reference Anton N, Cox PN, Massicotte MP et al (2009) Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 123:e453–458CrossRefPubMed Anton N, Cox PN, Massicotte MP et al (2009) Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 123:e453–458CrossRefPubMed
28.
go back to reference Sandoval JA, Sheehan MP, Stonerock CE et al (2008) Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg 47:837–843CrossRefPubMed Sandoval JA, Sheehan MP, Stonerock CE et al (2008) Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg 47:837–843CrossRefPubMed
29.
go back to reference Gurgey A, Aslan D (2001) Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 23:159–164CrossRefPubMed Gurgey A, Aslan D (2001) Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 23:159–164CrossRefPubMed
30.
go back to reference Gokce M, Altan I, Unal S et al (2012) Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors. Blood Coagul Fibrinolysis 23:434–439CrossRefPubMed Gokce M, Altan I, Unal S et al (2012) Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors. Blood Coagul Fibrinolysis 23:434–439CrossRefPubMed
31.
go back to reference Goldenberg NA (2005) Long-term outcomes of venous thrombosis in children. Curr Opin Hematol 12:370–376CrossRefPubMed Goldenberg NA (2005) Long-term outcomes of venous thrombosis in children. Curr Opin Hematol 12:370–376CrossRefPubMed
32.
go back to reference Revel-Vilk S, Brandao LR, Journeycake J et al (2012) Standardization of post-thrombotic syndrome definition and outcome assessment following upper venous system thrombosis in pediatric practice. J Thromb Haemost 10:2182–2185CrossRefPubMed Revel-Vilk S, Brandao LR, Journeycake J et al (2012) Standardization of post-thrombotic syndrome definition and outcome assessment following upper venous system thrombosis in pediatric practice. J Thromb Haemost 10:2182–2185CrossRefPubMed
33.
go back to reference Enden T, Klow NE, Sandvik L et al (2009) Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 7:1268–1275CrossRefPubMed Enden T, Klow NE, Sandvik L et al (2009) Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 7:1268–1275CrossRefPubMed
Metadata
Title
Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results
Authors
Matthew P. Lungren
Thomas J. Ward
Manish N. Patel
John M. Racadio
Kamlesh Kukreja
Publication date
01-10-2015
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2015
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-015-1209-3

Other articles of this Issue 3/2015

Journal of Thrombosis and Thrombolysis 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine